Notch3 intracellular domain accumulates in HepG2 cell line

Anticancer Research

Volumn 26, Issue 3 A, 2006, Pages 2123-2127

  Giovannini, Catia ^a   Lacchini, Michela ^a   Gramantieri, Laura ^a   Chieco, Pasquale ^a   Bolondi, Luigi ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Delta1; HCC; HES1; Jagged1; Notch3

Indexed keywords

JAGGED1; MEMBRANE PROTEIN; NOTCH3 RECEPTOR; PROTEIN DELTA1; TRANSCRIPTION FACTOR HES 1; UNCLASSIFIED DRUG;

ARTICLE; CELL PROLIFERATION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CALCIUM-BINDING PROTEINS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; GENE EXPRESSION; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOBLOTTING; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER NEOPLASMS; MEMBRANE PROTEINS; POLYMERASE CHAIN REACTION; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, NOTCH;

EID: 33745630080     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Blaumuller CM, Qi H, Zagouras P and Artavanis-Tsakonas S: Intracellular cleavage of Notch leads to a heterodimeric receptor on the plasma membrane. Cell 90: 281-291, 1997.
2. Sanchez-Irizarry C, Carpenter AC, Weng AP, Pear WS, Aster JC and Blacklow SC: Notch subunit heterodimerization and prevention of ligand-independent proteolytic activation depend, respectively, on a novel domain and the LNR repeats. Mol Cell Biol 24: 9265-9273, 2004.
3. Gray GE, Mann RS, Mitsiadis E, Henrique D, Carcangiu ML, Banks A, Leiman J, Ward D, Ish-Horowitz D and Artavanis-Tsakonas S: Human ligands of the Notch receptor. Am J Pathol 154: 785-794, 1999.
4. Yoneya T, Tahara T, Nagao K, Yamada Y, Yamamoto T, Osawa M, Miyatani S and Nishikawa M: Molecular cloning of delta-4, a new mouse and human Notch ligand. J Biochem 129: 27-34, 2001.
5. Brou C, Logeat F, Gupta N, Bessia C, LeBail O, Doedens JR, Cumano A, Roux P, Black RA and Israel A: A novel proteolytic cleavage involved in Notch signaling: the role of disintegrin-metalloprotease TACE. Mol Cell 5: 207-216, 2000.
6. Weinmaster G: Notch signaling: direct or what? Curr Opin Genet Dev 8: 436-442, 1998.
7. Jarriault S, Brou C, Logeat F, Schroeter EH, Kopan R and Israel A: Signalling downstream of activated mammalian Notch. Nature 377: 355-358, 1995.
8. Iso T, Kedes L and Hamamori Y: HES and HERP families: multiple effectors of the Notch signaling pathway. J Cell Physiol 194: 237-255, 2003.
9. Artavanis-Tsakonas S, Rand MD and Lake RJ: Notch signaling: cell fate control and signal integration in development. Science 284: 770-776, 1999.
10. Stier S, Cheng T, Dombkowiski D, Carlesso N and Scadden DT: Notch1 activation increases hematopoietic stem cell self-renewal in vivo and favors lymphoid over myeloid lineage outcome. Blood 99: 2369-2378, 2002.
11. Aster JC and Pear WS: Notch signaling in leukemia. Curr Opin Hematol 8: 237-244, 2001.
12. Politi K, Feirt N and Kitajewski J: Notch in mammary gland development and breast cancer. Sem Cancer Bio 14: 341-347, 2004.
13. Ye Q, Shieh JH, Morrone G and Moore MA: Expression of constitutively active Notch4 (Int-3) modulates myeloid proliferation and differentiation and promotes expansion of hematopoietic progenitors. Leukemia 18: 777-787, 2004.
14. Sriuranpong V, Borges MW, Ravi RK, Arnold DR, Nelkin BD, Baylin SB and Ball DW: Notch signaling induces cell cycle arrest in small cell lung cancer cells. Cancer Res 61: 3200-3205, 2001.
15. Shou j, Ross S, Koeppen H, De Sauvage FJ and Gao WQ: Dynamics of notch expression during murine prostate development and tumorigenesis. Cancer Res 61: 7291-7297, 2001.
16. Nicolas M, Wolfer A, Raj K, Kummer JA, Mill P, Van Noort M, Hui CC, Clevers H, Dotto GP and Radtke F: Notch1 functions as a tumor suppressor in mouse skin. Nat Genet 33: 416-421, 2003.
17. Qi R, An H, Yu Y, Zhang M, Liu S, Xu H, Guo Z, Cheng T and Cao X: Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosis. Cancer Res 63: 8323-8329, 2003.
18. Flynn DM, Nijjar S, Hubscher SG, de Goyet j de V, Kelly DA, Strain AJ and Crosby HA: The role of Notch receptor expression in bile duct development and diseases. J Path 204: 55-64, 2004.
19. Maillard I, He Y and Pear WS: From the yolk sac to the spleen: new roles for Notch in regulating hematopoiesis. Immunity 18: 587-589, 2003.
20. Campos AH, Wang W, Pollman MJ and Gibbons GH: Determinants of Notch-3 receptor expression and signaling in vascular smooth muscle cells. Circ Res 91: 999-1006, 2002.
21. Ruchoux MM, Domenga V, Brulin P, Maciazek J, Limol S, Tournier-Lasserve E and Joutel A: Transgenic mouse expressing mutant Notch3 develop vascular alterations characteristic of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Am J Pathol 162: 329-342, 2003.
22. Bellavia D, Campese AF, Vacca A, Gulino A and Screpanti I: Notch3, another Notch in T cell development. Semin Immunol 15: 107-112, 2003.
23. Fan X, Mikolaenko I, Elhassan I, Ni X, Wang Y, Ball D, Brat DJ, Perry A and Eberhart CG: Notch1 and Notch2 have opposite effects on embryonal brain tumor growth. Cancer Res 64: 7787-7793, 2004.
24. Aguilar RC and Wendland B: Ubiquitin: not just for proteasomes anymore. Curr Opin Cell Biol 15: 184-190, 2003.
25. Hicks C, Johnston SH, diSibio G, Collazo A, Vogt TF and Weinmaster G: Fringe differentially modulates Jagged1 and Delta1 signalling through Notch1 and Notch2. Nat Cell Biol 2: 515-520, 2000.